AblaCare aims to restore ovulation in PCOS patients through a simple, one-time, durable, minimally invasive treatment. AblaCare’s procedure is done transvaginally, under ultrasound guidance, and does not require general anesthesia. The technique can be performed in the clinic setting using the same minimally invasive access commonly used by fertility physicians for IVF.
Company’s Keywords:
7
medical devices
3000000
Outlook, Microsoft Office 365, Mobile Friendly, Apache, Google Font API, Google Tag Manager, Bootstrap Framework
2017